Douglas Abel serves as Executive at MANHATTAN PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Douglas Abel has executed 4 insider transactions totaling $3.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 1, 2007 involved receiving (via award) 10,000 shares valued at $2.7K.
Douglas Abel currently holds 45,000 shares of MANHATTAN PHARMACEUTICALS INC (MHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas Abel has been a net buyer of MHA stock. They have purchased $3.8K and sold $0 worth of shares.
Douglas Abel's most recent insider trade was on Aug 1, 2007, when they sold 10,000 shares at $0.27 per share.
Get notified when new Form 4 filings are submitted
| $0.36 |
| Discretionary |
| Jul 13, 2007 | MHA | $1.7K | Award | 5,000 | $0.34 | Discretionary |
| Jul 10, 2006 | MHA | $3.8K | Purchase | 5,000 | $0.75 | Discretionary |